American Diabetes Association
Browse
cd23-0043_Supplementary_Material.pdf (526.66 kB)

Deceived by Elevated A1C: Cases of Misdiagnosed Diabetes

Download (526.66 kB)
figure
posted on 2023-09-22, 18:56 authored by Kasper Munch Lauridsen, Julie Støy, Anne Winther-Larsen, Anders Abildgaard

A1C is an integrated biomarker for diagnosing diabetes and evaluating glycemic control in people with an established diabetes diagnosis. It has been recommended as one of the diagnostic screening criteria for more than a decade, both by the American Diabetes Association (ADA) and the World Health Organization (WHO) (1–3). However, the use of A1C as a diagnostic and monitoring tool is not without pitfalls. Conditions associated with increased or decreased erythrocyte turnover affect the A1C fraction (4), and in such cases, A1C may not reflect true average plasma glucose (5,6). Furthermore, analytical interference with A1C may occur because of genetic hemoglobin variants or metabolic alterations of hemoglobin (e.g., acetylation by acetylsalicylic acid) (7,8).

Funding

Novo Nordisk Fonden

Steno Diabetes Center Aarhus

History

Usage metrics

    Clinical Diabetes

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC